Search Results - Hitoshi Kiyoi

Refine Results
  1. 1
    Gene mutations of acute myeloid leukemia in the genome era

    Gene mutations of acute myeloid leukemia in the genome era by Tomoki Naoe, Hitoshi Kiyoi

    Published 2013
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  2. 2
    Mechanisms of action and resistance to all-trans retinoic acid (ATRA) and arsenic trioxide (As2O3) in acute promyelocytic leukemia

    Mechanisms of action and resistance to all-trans retinoic acid (ATRA) and arsenic trioxide (As2O3) in acute promyelocytic leukemia by Akihiro Tomita, Hitoshi Kiyoi, Tomoki Naoe

    Published 2013
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  3. 3
    Biology and management of primary effusion lymphoma

    Biology and management of primary effusion lymphoma by Kazuyuki Shimada, Fumihiko Hayakawa, Hitoshi Kiyoi

    Published 2018
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  4. 4
    <i>FLT3</i> mutations in acute myeloid leukemia: Therapeutic paradigm beyond inhibitor development

    <i>FLT3</i> mutations in acute myeloid leukemia: Therapeutic paradigm beyond inhibitor development by Hitoshi Kiyoi, Naomi Kawashima, Yuichi Ishikawa

    Published 2019
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  5. 5
    Nucleophosmin: A versatile molecule associated with hematological malignancies

    Nucleophosmin: A versatile molecule associated with hematological malignancies by Tomoki Naoe, Tatsuya Suzuki, Hitoshi Kiyoi, Takeshi Urano

    Published 2006
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  6. 6
    Co-expression of wild-type FLT3 attenuates the inhibitory effect of FLT3 inhibitor on FLT3 mutated leukemia cells

    Co-expression of wild-type FLT3 attenuates the inhibitory effect of FLT3 inhibitor on FLT3 mutated leukemia cells by Fangli Chen, Yuichi Ishikawa, Akimi Akashi, Tomoki Naoe, Hitoshi Kiyoi

    Published 2016
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  7. 7
    Missense mutations in PML-RARA are critical for the lack of responsiveness to arsenic trioxide treatment

    Missense mutations in PML-RARA are critical for the lack of responsiveness to arsenic trioxide treatment by Emi Goto, Akihiro Tomita, Fumihiko Hayakawa, Akihide Atsumi, Hitoshi Kiyoi, Tomoki Naoe

    Published 2011
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  8. 8
    Different antiapoptotic pathways between wild-type and mutated FLT3: insights into therapeutic targets in leukemia

    Different antiapoptotic pathways between wild-type and mutated FLT3: insights into therapeutic targets in leukemia by Yosuke Minami, Kazuhito Yamamoto, Hitoshi Kiyoi, Ryuzo Ueda, Hidehiko Saito, Tomoki Naoe

    Published 2003
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  9. 9
    Histone deacetylase inhibitor but not arsenic trioxide differentiates acute promyelocytic leukaemia cells with t(11;17) in combination with all‐<i>trans</i> retinoic acid

    Histone deacetylase inhibitor but not arsenic trioxide differentiates acute promyelocytic leukaemia cells with t(11;17) in combination with all‐<i>trans</i> retinoic acid by Kunio Kitamura, Shinetsu Hoshi, Mitsuru Koike, Hitoshi Kiyoi, Hidehiko Saito, Tomoki Naoe

    Published 2000
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  10. 10
    Small‐molecule Hedgehog inhibitor attenuates the leukemia‐initiation potential of acute myeloid leukemia cells

    Small‐molecule Hedgehog inhibitor attenuates the leukemia‐initiation potential of acute myeloid leukemia cells by Nobuaki Fukushima, Yosuke Minami, Seiji Kakiuchi, Yachiyo Kuwatsuka, Fumihiko Hayakawa, Catoriona Jamieson, Hitoshi Kiyoi, Tomoki Naoe

    Published 2016
    Get full text
    Artigo
    Save to List
    Saved in:
  11. 11
    Lyn is an important component of the signal transduction pathway specific to FLT3/ITD and can be a therapeutic target in the treatment of AML with FLT3/ITD

    Lyn is an important component of the signal transduction pathway specific to FLT3/ITD and can be a therapeutic target in the treatment of AML with FLT3/ITD by Masanori Okamoto, Fumihiko Hayakawa, Yasuyoshi Miyata, Kouichi Watamoto, Nobuhiko Emi, Akihiro Abe, Hitoshi Kiyoi, Masayuki Towatari, T Naoe

    Published 2007
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  12. 12
    Down-regulation of CD20 expression in B-cell lymphoma cells after treatment with rituximab-containing combination chemotherapies: its prevalence and clinical significance

    Down-regulation of CD20 expression in B-cell lymphoma cells after treatment with rituximab-containing combination chemotherapies: its prevalence and clinical significance by Junji Hiraga, Akihiro Tomita, Takumi Sugimoto, Kazuyuki Shimada, Masafumi Ito, Shigeo Nakamura, Hitoshi Kiyoi, Tomohiro Kinoshita, Tomoki Naoe

    Published 2009
    Get full text
    Artigo
    Save to List
    Saved in:
  13. 13
    Pyruvate secreted from patient‐derived cancer‐associated fibroblasts supports survival of primary lymphoma cells

    Pyruvate secreted from patient‐derived cancer‐associated fibroblasts supports survival of primary lymphoma cells by Akihiko Sakamoto, Shunsuke Kunou, Kazuyuki Shimada, Makoto Tsunoda, Tomohiro Aoki, Chisako Iriyama, Akihiro Tomita, Shigeo Nakamura, Fumihiko Hayakawa, Hitoshi Kiyoi

    Published 2018
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  14. 14
    Epstein-Barr virus lytic gene BNRF1 promotes B-cell lymphomagenesis via IFI27 upregulation

    Epstein-Barr virus lytic gene BNRF1 promotes B-cell lymphomagenesis via IFI27 upregulation by Ken Sagou, Yoshitaka Sato, Yusuke Okuno, Takahiro Watanabe, Tomoki Inagaki, Yashiro Motooka, Shinya Toyokuni, Takayuki Murata, Hitoshi Kiyoi, Hiroshi Kimura

    Published 2024
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  15. 15
    Phase I trial of volasertib, a Polo‐like kinase inhibitor, in Japanese patients with acute myeloid leukemia

    Phase I trial of volasertib, a Polo‐like kinase inhibitor, in Japanese patients with acute myeloid leukemia by Yukio Kobayashi, Takahiro Yamauchi, Hitoshi Kiyoi, Toru Sakura, Tomoko Hata, Kiyoshi Ando, Aiko Watabe, Akiko Harada, Tillmann Taube, Yasushi Miyazaki, Tomoki Naoe

    Published 2015
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  16. 16
    Sustained inhibition of CSF1R signaling augments antitumor immunity through inhibiting tumor-associated macrophages

    Sustained inhibition of CSF1R signaling augments antitumor immunity through inhibiting tumor-associated macrophages by Takahiko Sato, Daisuke Sugiyama, Jun Koseki, Yasuhiro Kojima, Satomi Hattori, Kazuki Sone, Hitomi Nishinakamura, Tomohiro Ishikawa, Yuichi Ishikawa, T. Kato, Hitoshi Kiyoi, Hiroyoshi Nishikawa

    Published 2025
    Get full text
    Artigo
    Save to List
    Saved in:
  17. 17
    A Tet-On Inducible System for Controlling CD19-Chimeric Antigen Receptor Expression upon Drug Administration

    A Tet-On Inducible System for Controlling CD19-Chimeric Antigen Receptor Expression upon Drug Administration by Reona Sakemura, Seitaro Terakura, Keisuke Watanabe, Jakrawadee Julamanee, Erina Takagi, Kotaro Miyao, Daisuke Koyama, Tatsunori Goto, Ryo Hanajiri, Tetsuya Nishida, Makoto Murata, Hitoshi Kiyoi

    Published 2016
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  18. 18
    Human iPSC-derived CD4+ Treg-like cells engineered with chimeric antigen receptors control GvHD in a xenograft model

    Human iPSC-derived CD4+ Treg-like cells engineered with chimeric antigen receptors control GvHD in a xenograft model by Hisashi Yano, Keiko Koga, Takayuki Sato, Tokuyuki Shinohara, Shoichi Iriguchi, Atsushi Matsuda, Kazuki Nakazono, Maki Shioiri, Y. Miyake, Yoshiaki Kassai, Hitoshi Kiyoi, Shin Kaneko

    Published 2024
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  19. 19
    Exosomes secreted from cancer-associated fibroblasts elicit anti-pyrimidine drug resistance through modulation of its transporter in malignant lymphoma

    Exosomes secreted from cancer-associated fibroblasts elicit anti-pyrimidine drug resistance through modulation of its transporter in malignant lymphoma by Shunsuke Kunou, Kazuyuki Shimada, Mika Takai, Akihiko Sakamoto, Tomohiro Aoki, Tomoya Hikita, Yusuke Kagaya, Eisuke Iwamoto, Masashi Sanada, Satoko Shimada, Fumihiko Hayakawa, Chitose Oneyama, Hitoshi Kiyoi

    Published 2021
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  20. 20
    Ectopic Expression of <i>MAFB</i> Gene in Human Myeloma Cells Carrying (14;20)(q32;q11) Chromosomal Translocations

    Ectopic Expression of <i>MAFB</i> Gene in Human Myeloma Cells Carrying (14;20)(q32;q11) Chromosomal Translocations by Ichiro Hanamura, Shinsuke Iida, Yumiko Akano, Yoshihito Hayami, Miyuki Kato, Kazuhisa Miura, Shinsuke Harada, Shogo Banno, Atsushi Wakita, Hitoshi Kiyoi, Tomoki Naoe, Shiro Shimizu, Shin‐ichi Sonta, Masakazu Nitta, Masafumi Taniwaki, Ryuzo Ueda

    Published 2001
    Get full text Get full text
    Artigo
    Save to List
    Saved in:

Search Tools: